Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine

Modulation of the pentose phosphate pathway alters phase I metabolism of testosterone and dextromethorphan in HepG2 cells

(2015) Wen-jing Xiao et al.   ACTA PHARMACOLOGICA SINICA

Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice

(2015) Miaoran Ning et al.   BIOCHEMICAL PHARMACOLOGY

Intake of St John's wort improves the glucose tolerance in healthy subjects who ingest metformin compared with metformin alone

(2015) Tore Bjerregaard Stage et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Influence of gestational diabetes on the stereoselective pharmacokinetics and placental distribution of metoprolol and its metabolites in parturients

(2015) Natalícia de Jesus Antunes et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

The genetics of Parkinson's disease

(2015) Stephen Mullin et al.   BRITISH MEDICAL BULLETIN

Pharmacokinetic Interactions Between Herbal Medicines and Prescribed Drugs: Focus on Drug Metabolic Enzymes and Transporters

(2015) Qiang Meng et al.   CURRENT DRUG METABOLISM

Alcohol Addiction: A Molecular Biology Perspective

(2015) Giampiero Ferraguti et al.   CURRENT MEDICINAL CHEMISTRY

Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

(2015) Gideon M. Hirschfield et al.   GASTROENTEROLOGY

Molecular Evolution of the CYP2D Subfamily in Primates: Purifying Selection on Substrate Recognition Sites without the Frequent or Long-Tract Gene Conversion

(2015) Yoshiki Yasukochi et al.   Genome Biology and Evolution

The Kruppel-like factors in female reproductive system pathologies

(2015) R. C. M. Simmen et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

Parkinson's disease

(2015) Lorraine V Kalia et al.   LANCET

Alzheimer's disease and other dementias: advances in 2014

(2015) Randall Bateman   LANCET NEUROLOGY

Neuroinflammation in Alzheimer's disease

(2015) Michael T Heneka et al.   LANCET NEUROLOGY

Alzheimer disease (AD) specific transcription, DNA methylation and splicing in twenty AD associated loci

(2015) Crystal Humphries et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer’s disease

(2015) Elizabeta Gjoneska et al.   NATURE

Innate immunity in Alzheimer's disease

(2015) Michael T Heneka et al.   NATURE IMMUNOLOGY

Parkinson disease GWAS: The question of lumping or splitting is back again

(2015) J. Simon-Sanchez et al.   NEUROLOGY

The resolution of inflammation: Principles and challenges

(2015) Sarah E. Headland et al.   SEMINARS IN IMMUNOLOGY

Amyloid biomarkers in Alzheimer's disease

(2015) Kaj Blennow et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The Chemokine System in Innate Immunity

(2015) Caroline L. Sokol et al.   Cold Spring Harbor Perspectives in Biology

Differences in the Epigenetic Regulation of Cytochrome P450 Genes between Human Embryonic Stem Cell-Derived Hepatocytes and Primary Hepatocytes

(2015) Han-Jin Park et al.   PLoS One

2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease

(2014) Keith N. Fargo et al.   Alzheimers & Dementia

Deaths in the United States among persons with Alzheimer's disease (2010–2050)

(2014) Jennifer Weuve et al.   Alzheimers & Dementia

Apolipoprotein E in Alzheimer's Disease: An Update

(2014) Jin-Tai Yu et al.   Annual Review of Neuroscience

Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers

(2014) Christiane Reitz et al.   BIOCHEMICAL PHARMACOLOGY

TAM receptors, Gas6, and protein S: roles in inflammation and hemostasis

(2014) J. H. M. van der Meer et al.   BLOOD

Identification of a novel Parkinson’s disease locus via stratified genome-wide association study

(2014) Erin M Hill-Burns et al.   BMC GENOMICS

Genetic and epigenetic regulation of gene expression in fetal and adult human livers

(2014) Marc Bonder et al.   BMC GENOMICS

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study

(2014) Malin von Otter et al.   BMC Medical Genetics

Interleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3

(2014) S A A Patel et al.   BRITISH JOURNAL OF CANCER

Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations

(2014) Yuan Ji et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents

(2014) R Donald Harvey et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

ABC Transporters in Multidrug Resistance and Pharmacokinetics, and Strategies for Drug Development

(2014) Young Choi et al.   CURRENT PHARMACEUTICAL DESIGN

Cytochrome P450 enzyme regulation by glucocorticoids and consequences in terms of drug interaction

(2014) Petra Matoulková et al.   Expert Opinion on Drug Metabolism & Toxicology

Genetic markers for diagnosis and pathogenesis of Alzheimer's disease

(2014) Dong Hee Kim et al.   GENE

Alzheimer’s Disease—A Panorama Glimpse

(2014) Li Zhao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Hepatic cytochrome P450 ubiquitination: Conformational phosphodegrons for E2/E3 recognition?

(2014) Maria Almira Correia et al.   IUBMB LIFE

Pregnane X Receptor as the “Sensor and Effector” in Regulating Epigenome

(2014) Xi Ma et al.   JOURNAL OF CELLULAR PHYSIOLOGY

A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers

(2014) C. Briciu et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Structural diversity of ABC transporters

(2014) Josy ter Beek et al.   JOURNAL OF GENERAL PHYSIOLOGY

Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease

(2014) Neeraj Kumar Singh et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Pathways to Alzheimer's disease

(2014) J. Hardy et al.   JOURNAL OF INTERNAL MEDICINE

A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies

(2014) Dany Spaggiari et al.   JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

Quantitative assessment of CYP2D6 polymorphisms and risk of Alzheimer's disease: A meta-analysis

(2014) Yu Lu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Targeting the β secretase BACE1 for Alzheimer's disease therapy

(2014) Riqiang Yan et al.   LANCET NEUROLOGY

Association of CYP1A1 and CYP2D6 gene polymorphisms with head and neck cancer in Tunisian patients

(2014) Rim Khlifi et al.   MOLECULAR BIOLOGY REPORTS

Identifying the Association Between Alzheimer’s Disease and Parkinson’s Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network

(2014) Guiyou Liu et al.   MOLECULAR NEUROBIOLOGY

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

(2014) Mike A Nalls et al.   NATURE GENETICS

Alzheimer’s Disease Genetics: From the Bench to the Clinic

(2014) Celeste M. Karch et al.   NEURON

MicroRNAs as regulators of drug transporters, drug-metabolizing enzymes, and tight junctions: Implication for intestinal barrier function

(2014) Kenji Ikemura et al.   PHARMACOLOGY & THERAPEUTICS

Human FXR Regulates SHP Expression through Direct Binding to an LRH-1 Binding Site, Independent of an IR-1 and LRH-1

(2014) Martijn O. Hoeke et al.   PLoS One

Medicinal Herbs and Therapeutic Drugs Interactions

(2014) Eman M. Alissa   THERAPEUTIC DRUG MONITORING

Genome-Wide Discovery of Drug-Dependent Human Liver Regulatory Elements

(2014) Robin P. Smith et al.   PLoS Genetics

Amyloid-β and Tau

(2014) George S. Bloom   JAMA Neurology

Beyond interferon: rationale and prospects for newer treatment paradigms for chronic hepatitis C

(2014) Karoll J. Cortez et al.   Therapeutic Advances in Chronic Disease

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

(2013) William T. Wissemann et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts

(2013) Priya Duggal et al.   ANNALS OF INTERNAL MEDICINE

Induction of Influx and Efflux Transporters and Cytochrome P450 3A4 in Primary Human Hepatocytes by Rifampin, Rifabutin, and Rifapentine

(2013) Beth Williamson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Current and future therapies for hepatitis C virus infection: from viral proteins to host targets

(2013) Muhammad Imran et al.   ARCHIVES OF VIROLOGY

The dynamic nature of the kinome

(2013) Lee M. Graves et al.   BIOCHEMICAL JOURNAL

The cytochrome P450 complement (CYPome) ofMycosphaerella graminicola

(2013) Alun W. Newsome et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

SnapShot: Pathobiology of Alzheimer's Disease

(2013) Dennis J. Selkoe   CELL

Molecular Pathways: MERTK Signaling in Cancer

(2013) C. T. Cummings et al.   CLINICAL CANCER RESEARCH

Chronological Effects of Rifampicin Discontinuation on Cytochrome P450 Activity in Healthy Japanese Volunteers, Using the Cocktail Method

(2013) N Inui et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes

(2013) U M Zanger et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily

(2013) Tomas Smutny et al.   CURRENT DRUG METABOLISM

The Evolution of Cytochrome P450 Enzymes as Biocatalysts in Drug Discovery and Development

(2013) Elizabeth Gillam et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Nuclear receptors in regulation of biotransformation enzymes and drug transporters in the placental barrier

(2013) Petr Pavek et al.   DRUG METABOLISM REVIEWS

The endogenous substrates of brain CYP2D

(2013) Xiaoshuang Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

(2013) Sunder Mudaliar et al.   GASTROENTEROLOGY

Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha in Maturity-Onset Diabetes of the Young and Hyperinsulinemic Hypoglycemia

(2013) Kevin Colclough et al.   HUMAN MUTATION

Cytochrome P450 isoforms are differently up-regulated in aflatoxin B1-exposed human lymphocytes and monocytes

(2013) Abbas Bahari et al.   IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice

(2013) Kwi Hye Koh et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Drug-Induced Liver Injury: The Role of Drug Metabolism and Transport

(2013) Alberto Corsini et al.   JOURNAL OF CLINICAL PHARMACOLOGY

A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region

(2013) Yuji Urabe et al.   JOURNAL OF HEPATOLOGY

Recent advances in Parkinson’s disease genetics

(2013) Steven Lubbe et al.   JOURNAL OF NEUROLOGY

CYP2D6 phenotypes and Parkinson's disease risk: A meta-analysis

(2013) Yu Lu et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport

(2013) Catherine K. Yeung et al.   KIDNEY INTERNATIONAL

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

(2013) Harvey A Whiteford et al.   LANCET

Treating HCV in HIV 2013: on the cusp of change

(2013) Valérie Martel-Laferrière et al.   LIVER INTERNATIONAL

Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer’s disease

(2013) Carlos Cruchaga et al.   NATURE

Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease

(2013) Herve Rhinn et al.   NATURE

HCV causes systemic disorders that can be cured

(2013) Francesco Negro   Nature Reviews Gastroenterology & Hepatology

Advances in the genetics of Parkinson disease

(2013) Joanne Trinh et al.   Nature Reviews Neurology

CYP2D6 -1584C>G promoter polymorphism and debrisoquine ultrarapid hydroxylation in healthy volunteers

(2013) Adrian LLerena et al.   PHARMACOGENOMICS

NADPH P450 oxidoreductase: Structure, function, and pathology of diseases

(2013) Amit V. Pandey et al.   PHARMACOLOGY & THERAPEUTICS

Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation

(2013) Ulrich M. Zanger et al.   PHARMACOLOGY & THERAPEUTICS

Epigenetic Changes in Gene Expression for Drug-Metabolizing Enzymes and Transporters

(2013) In-Wha Kim et al.   PHARMACOTHERAPY

Unusual properties of the cytochrome P450 superfamily

(2013) D. C. Lamb et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Human cytochromes P450 in health and disease

(2013) D. W. Nebert et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Microbial cytochromes P450: biodiversity and biotechnology. Where do cytochromes P450 come from, what do they do and what can they do for us?

(2013) S. L. Kelly et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

Systematic Functional Study of Cytochrome P450 2D6 Promoter Polymorphisms in the Chinese Han Population

(2013) Xueli Gong et al.   PLoS One

CYP2D6*4 Allele Polymorphism Increases the Risk of Parkinson’s Disease: Evidence from Meta-Analysis

(2013) Yu Lu et al.   PLoS One

Novel Single Nucleotide Polymorphism Markers for Low Dose Aspirin-Associated Small Bowel Bleeding

(2013) Akiko Shiotani et al.   PLoS One

Possibility of Decrease in CYP1A2 Function in Patients With End-Stage Renal Disease

(2013) Masayuki Tsujimoto et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Transcriptional Suppression of CYP2A13 Expression by Lipopolysaccharide in Cultured Human Lung Cells and the Lungs of a CYP2A13-Humanized Mouse Model

(2013) Hong Wu et al.   TOXICOLOGICAL SCIENCES

β-Secretase: its biology as a therapeutic target in diseases

(2013) Haibo Wang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

CYP2D6 T188C variant is associated with lung cancer risk in the Chinese population

(2013) Yan Huang et al.   TUMOR BIOLOGY

Potential role of CYP2D6 in the central nervous system

(2013) Jie Cheng et al.   XENOBIOTICA

Biology of the TAM Receptors

(2013) G. Lemke   Cold Spring Harbor Perspectives in Biology

Genetics of Parkinson's Disease

(2013) C. Klein et al.   Cold Spring Harbor Perspectives in Medicine

Maturity onset diabetes of the young: identification and diagnosis

(2013) T. J. McDonald et al.   ANNALS OF CLINICAL BIOCHEMISTRY

NADPH–cytochrome P450 oxidoreductase: Prototypic member of the diflavin reductase family

(2012) Takashi Iyanagi et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Alzheimer Mechanisms and Therapeutic Strategies

(2012) Yadong Huang et al.   CELL

Systematic Functional Prioritization of Protein Posttranslational Modifications

(2012) Pedro Beltrao et al.   CELL

Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs

(2012) Miroslav Dostalek et al.   CLINICAL PHARMACOKINETICS

Update on rifampin, rifabutin, and rifapentine drug interactions

(2012) Anne M. Baciewicz et al.   CURRENT MEDICAL RESEARCH AND OPINION

Farnesoid X receptor: from medicinal chemistry to clinical applications

(2012) Stefano Fiorucci et al.   Future Medicinal Chemistry

Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

(2012) Etienne Patin et al.   GASTROENTEROLOGY

Krüppel-Like Factor 9 and Progesterone Receptor Coregulation of Decidualizing Endometrial Stromal Cells: Implications for the Pathogenesis of Endometriosis

(2012) John Mark P. Pabona et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease

(2012) Tung-Ming Leung et al.   JOURNAL OF HEPATOLOGY

Profiling the kinome: Current capabilities and future challenges

(2012) James D.R. Knight et al.   Journal of Proteomics

Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection

(2012) F. Girardin et al.   JOURNAL OF VIRAL HEPATITIS

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Rafael Lozano et al.   LANCET

Epigenetic-dependent regulation of drug transport and metabolism: an update

(2012) Marina Kacevska et al.   PHARMACOGENOMICS

Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside

(2012) Alessio Aghemo et al.   Seminars in Immunopathology

US Mortality from Liver Cirrhosis and Alcoholic Liver Disease in 1999–2004: Regional and State Variation in Relation to Per Capita Alcohol Consumption

(2012) Anthony P. Polednak   SUBSTANCE USE & MISUSE

Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase

(2012) Yi Sun et al.   Protein & Cell

Role of Rifampin-Based Combination Therapy for Severe Community-Acquired Legionella pneumophila Pneumonia

(2011) Terra R Varner et al.   ANNALS OF PHARMACOTHERAPY

Molecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 EnzymesMolecular Mechanisms Regulating the Mitochondrial Targeting of Microsomal Cytochrome P450 Enzymes

(2011) Taeho Ahn et al.   CURRENT DRUG METABOLISM

Steroid Regulation of Drug-Metabolizing Cytochromes P450

(2011) Katalin Monostory et al.   CURRENT DRUG METABOLISM

Complex Drug Interactions of HIV Protease Inhibitors 2: In Vivo Induction and In Vitro to In Vivo Correlation of Induction of Cytochrome P450 1A2, 2B6, and 2C9 by Ritonavir or Nelfinavir

(2011) B. J. Kirby et al.   DRUG METABOLISM AND DISPOSITION

Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers

(2011) G. Zadoyan et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Bimodal targeting of cytochrome P450s to endoplasmic reticulum and mitochondria: the concept of chimeric signals

(2011) Narayan G. Avadhani et al.   FEBS Journal

Evolution of the CYP2D gene cluster in humans and four non-human primates

(2011) Yoshiki Yasukochi et al.   GENES & GENETIC SYSTEMS

Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model

(2011) Edith Hintermann et al.   JOURNAL OF AUTOIMMUNITY

Identification and biology of β-secretase

(2011) Patty C. Kandalepas et al.   JOURNAL OF NEUROCHEMISTRY

Alzheimer's disease

(2011) Clive Ballard et al.   LANCET

MicroRNAs from biology to future pharmacotherapy: Regulation of cytochrome P450s and nuclear receptors

(2011) Miki Nakajima et al.   PHARMACOLOGY & THERAPEUTICS

Phenobarbital Mediates an Epigenetic Switch at the Constitutive Androstane Receptor (CAR) Target Gene Cyp2b10 in the Liver of B6C3F1 Mice

(2011) Harri Lempiäinen et al.   PLoS One

Functional Evaluation of Genetic and Environmental Regulators of P450 mRNA Levels

(2011) Dazhi Wang et al.   PLoS One

Epigenetic regulation of drug processing genes

(2011) Curtis D. Klaassen et al.   TOXICOLOGY MECHANISMS AND METHODS

Hepatic FXR: key regulator of whole-body energy metabolism

(2011) João Soeiro Teodoro et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

The tubby family proteins

(2011) Saikat Mukhopadhyay et al.   GENOME BIOLOGY

Nuclear bile acid receptor FXR in the hepatic regeneration

(2010) Wei-Dong Chen et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Fyn-Tau-Amyloid: A Toxic Triad

(2010) Christian Haass et al.   CELL

Cell Signaling by Receptor Tyrosine Kinases

(2010) Mark A. Lemmon et al.   CELL

CYP-Mediated Therapeutic Protein-Drug Interactions

(2010) Jang-Ik Lee et al.   CLINICAL PHARMACOKINETICS

Herbal Interactions with Anticancer Drugs: Mechanistic and Clinical Considerations

(2010) An-Kui Yang et al.   CURRENT MEDICINAL CHEMISTRY

HNF4α—role in drug metabolism and potential drug target?

(2010) Wendy W Hwang-Verslues et al.   CURRENT OPINION IN PHARMACOLOGY

Cytochrome P450 2D6 as a Model Antigen

(2010) Urs Christen et al.   DIGESTIVE DISEASES

Cynomolgus Monkey CYP2D44 Newly Identified in Liver, Metabolizes Bufuralol, and Dextromethorphan

(2010) Y. Uno et al.   DRUG METABOLISM AND DISPOSITION

LKM-1 Sera from Autoimmune Hepatitis Patients that Recognize ERp57, Carboxylesterase 1 and CYP2D6

(2010) Ryo Komurasaki et al.   Drug Metabolism and Pharmacokinetics

Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients

(2010) Teresa Maria J. P. Carvalho et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations

(2010) Bao Ting Zhu   Expert Opinion on Drug Metabolism & Toxicology

Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis

(2010) Albert J. Czaja et al.   GASTROENTEROLOGY

Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver

(2010) X. Yang et al.   GENOME RESEARCH

The Impact of Paroxetine Coadministration on Stereospecific Carvedilol Pharmacokinetics

(2010) Stephen M. Stout et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues

(2010) Sun Jung Kim et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Simultaneous Absolute Quantification of 11 Cytochrome P450 Isoforms in Human Liver Microsomes by Liquid Chromatography Tandem Mass Spectrometry with In Silico Target Peptide Selection

(2010) Hirotaka Kawakami et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

(2010) Lars M. Ittner et al.   NATURE REVIEWS NEUROSCIENCE

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rifamycins – Obstacles and opportunities

(2010) Paul A. Aristoff et al.   TUBERCULOSIS

Human CYP2E1 is regulated by miR-378

(2009) Takuya Mohri et al.   BIOCHEMICAL PHARMACOLOGY

Caspases and Kinases in a Death Grip

(2009) Manabu Kurokawa et al.   CELL

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

(2009) Shu-Feng Zhou   CLINICAL PHARMACOKINETICS

The Influence of Chronic Renal Failure on Drug Metabolism and Transport

(2009) A W Dreisbach   CLINICAL PHARMACOLOGY & THERAPEUTICS

Transcriptional Regulation of Cytochrome P450 Genes by the Nuclear Receptor Hepatocyte Nuclear Factor 4-Alpha

(2009) Ramiro Jover et al.   CURRENT DRUG METABOLISM

Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

(2009) Shu-Feng Zhou et al.   CURRENT MEDICINAL CHEMISTRY

Evaluation of Recombinant Cytochrome P450 Enzymes as an in Vitro System for Metabolic Clearance Predictions

(2009) R. A. Stringer et al.   DRUG METABOLISM AND DISPOSITION

The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine and Its Single Enantiomers

(2009) M. R. Meyer et al.   DRUG METABOLISM AND DISPOSITION

Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism

(2009) John YL Chiang   Expert Opinion on Drug Metabolism & Toxicology

Application of mechanism-based CYP inhibition for predicting drug–drug interactions

(2009) Zhi-Wei Zhou et al.   Expert Opinion on Drug Metabolism & Toxicology

Mitochondrial Targeting of Cytochrome P450 Proteins Containing NH2-terminal Chimeric Signals Involves an Unusual TOM20/TOM22 Bypass Mechanism

(2009) Hindupur K. Anandatheerthavarada et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes

(2009) D. J. Waxman et al.   MOLECULAR PHARMACOLOGY

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Relevance ofCYP2D6-1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients

(2009) Pedro Dorado et al.   PHARMACOGENOMICS

Epigenetic and microRNA-dependent control of cytochrome P450 expression: a gap between DNA and protein

(2009) Alvin Gomez et al.   PHARMACOGENOMICS

Mechanistic aspects of CYP74 allene oxide synthases and related cytochrome P450 enzymes

(2009) Alan R. Brash   PHYTOCHEMISTRY

Identification of an Endogenous Ligand Bound to a Native Orphan Nuclear Receptor

(2009) Xiaohui Yuan et al.   PLoS One

Modification-specific proteomics: Strategies for characterization of post-translational modifications using enrichment techniques

(2009) Yingming Zhao et al.   PROTEOMICS

Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions

(2008) Ai-Ming Yu   AAPS Journal

Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical

(2008) Michael Sinz et al.   AAPS Journal

Intracellular transport and localization of microsomal cytochrome P450

(2008) Etienne P. A. Neve et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy

(2008) Leslie J. Dickmann et al.   BIOCHEMICAL PHARMACOLOGY

Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration

(2008) C. Ulbricht et al.   CURRENT DRUG METABOLISM

Cytochrome P450 Turnover: Regulation of Synthesis and Degradation, Methods for Determining Rates, and Implications for the Prediction of Drug Interactions

(2008) Jiansong Yang et al.   CURRENT DRUG METABOLISM

Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues

(2008) Petr Pavek et al.   CURRENT DRUG METABOLISM

Developmental Changes in Human Liver CYP2D6 Expression

(2008) J. C. Stevens et al.   DRUG METABOLISM AND DISPOSITION

Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes

(2008) W.-Y. Zhang et al.   DRUG METABOLISM AND DISPOSITION

Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57)

(2008) K. Sakuyama et al.   DRUG METABOLISM AND DISPOSITION

Regulation of Drug-Metabolizing Enzymes and Transporters in Infection, Inflammation, and Cancer

(2008) E. T. Morgan et al.   DRUG METABOLISM AND DISPOSITION

Decreased Expression of Cytochromes P450 1A2, 2E1, and 3A4 and Drug Transporters Na+-Taurocholate-Cotransporting Polypeptide, Organic Cation Transporter 1, and Organic Anion-Transporting Peptide-C Correlates with the Progression of Liver Fibrosis in Chronic Hepatitis C Patients

(2008) K. Nakai et al.   DRUG METABOLISM AND DISPOSITION

Coordinated induction of drug transporters and phase I and II metabolism in human liver slices

(2008) P. Olinga et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The effect of chronic renal failure on drug metabolism and transport

(2008) Albert W Dreisbach et al.   Expert Opinion on Drug Metabolism & Toxicology

Sex-specific differences in CYP450 isoforms in humans

(2008) Marissa J Scandlyn et al.   Expert Opinion on Drug Metabolism & Toxicology

Paroxetine

(2008) Siu Wa Tang et al.   EXPERT OPINION ON PHARMACOTHERAPY

Genetic polymorphism of hepatocyte nuclear factor-4α influences human cytochrome P450 2D6 activity

(2008) Sang Seop Lee et al.   HEPATOLOGY

Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

(2008) M. Sousa et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A Role for Protein Phosphorylation in Cytochrome P450 3A4 Ubiquitin-dependent Proteasomal Degradation

(2008) YongQiang Wang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Characterization of Cullin-box Sequences That Direct Recruitment of Cul2-Rbx1 and Cul5-Rbx2 Modules to Elongin BC-based Ubiquitin Ligases

(2008) Nawel Mahrour et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Structural Analysis of CYP2R1 in Complex with Vitamin D3

(2008) Natallia Strushkevich et al.   JOURNAL OF MOLECULAR BIOLOGY

The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6

(2008) N. T. Snider et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Distinction between Human Cytochrome P450 (CYP) Isoforms and Identification of New Phosphorylation Sites by Mass Spectrometry

(2008) Gorden Redlich et al.   JOURNAL OF PROTEOME RESEARCH

Aromatase is phosphorylated in situ at serine-118

(2008) Todd W. Miller et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Linking the kinome and phosphorylome—a comprehensive review of approaches to find kinase targets

(2008) Richelle Sopko et al.   Molecular BioSystems

Clinical assessment of CYP2D6‐mediated herb–drug interactions in humans: Effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, andEchinacea

(2008) Bill J. Gurley et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Development of CYP2D6 and CYP3A4 in the First Year of Life

(2007) TN Johnson et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS